127 related articles for article (PubMed ID: 36646187)
21. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
[No Abstract] [Full Text] [Related]
22. PRDX4, an endoplasmic reticulum-localized peroxiredoxin at the crossroads between enzymatic oxidative protein folding and nonenzymatic protein oxidation.
Zito E
Antioxid Redox Signal; 2013 May; 18(13):1666-74. PubMed ID: 23025503
[TBL] [Abstract][Full Text] [Related]
23. Suppression of PRDX4 inhibits cell proliferation and invasion of ectopic endometrial stromal cells in endometriosis.
Luo Y; Zou Y; Li LP; Wang ZZ; Wang LQ; Zhang ZY; Liu FY; Huang OP
Gynecol Endocrinol; 2020 Oct; 36(10):895-901. PubMed ID: 32436404
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis.
Zheng J; Guo X; Nakamura Y; Zhou X; Yamaguchi R; Zhang J; Ishigaki Y; Uramoto H; Yamada S
Oxid Med Cell Longev; 2020; 2020():8262730. PubMed ID: 33456675
[TBL] [Abstract][Full Text] [Related]
25. Implication of Differential Peroxiredoxin 4 Expression with Age in Ovaries of Mouse and Human for Ovarian Aging.
Qian Y; Shao L; Yuan C; Jiang CY; Liu J; Gao C; Gao L; Cui YG; Jiang SW; Liu JY; Meng Y
Curr Mol Med; 2016; 16(3):243-51. PubMed ID: 26917265
[TBL] [Abstract][Full Text] [Related]
26. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
Gong X; Gong Y; Wu G; Ke H
Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
[TBL] [Abstract][Full Text] [Related]
28. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer.
Mei J; Hao L; Liu X; Sun G; Xu R; Wang H; Liu C
Biomark Res; 2019; 7():16. PubMed ID: 31402980
[TBL] [Abstract][Full Text] [Related]
30. Peroxiredoxins prevent oxidative stress during human sperm capacitation.
Lee D; Moawad AR; Morielli T; Fernandez MC; O'Flaherty C
Mol Hum Reprod; 2017 Feb; 23(2):106-115. PubMed ID: 28025393
[TBL] [Abstract][Full Text] [Related]
31. TNF-related apoptosis-inducing ligand suppresses PRDX4 expression.
Wang HQ; Du ZX; Liu BQ; Gao YY; Meng X; Guan Y; Zhang HY
FEBS Lett; 2009 May; 583(9):1511-5. PubMed ID: 19364504
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress and alterations of peroxiredoxins in aged hearts.
Chen Q; Thompson J; Hu Y; Lesnefsky EJ
Mech Ageing Dev; 2023 Oct; 215():111859. PubMed ID: 37661065
[TBL] [Abstract][Full Text] [Related]
33. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.
Chang KP; Yu JS; Chien KY; Lee CW; Liang Y; Liao CT; Yen TC; Lee LY; Huang LL; Liu SC; Chang YS; Chi LM
J Proteome Res; 2011 Nov; 10(11):4935-47. PubMed ID: 21859152
[TBL] [Abstract][Full Text] [Related]
34. PRDX4 and Its Roles in Various Cancers.
Jia W; Chen P; Cheng Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819864313. PubMed ID: 31311441
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
[TBL] [Abstract][Full Text] [Related]
36. Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure.
Homma T; Kurahashi T; Lee J; Nabeshima A; Yamada S; Fujii J
Oxid Med Cell Longev; 2018; 2018():2812904. PubMed ID: 30050648
[TBL] [Abstract][Full Text] [Related]
37. Consequences of a peroxiredoxin 4 (Prdx4) deficiency on learning and memory in mice.
Homma T; Fujiwara H; Osaki T; Fujii S; Fujii J
Biochem Biophys Res Commun; 2022 Sep; 621():32-38. PubMed ID: 35809345
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and
Zhou H; Li L; Chen J; Hou S; Zhou T; Xiong Y
Front Oncol; 2023; 13():1136738. PubMed ID: 36969053
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard.
Tahmasbpour Marzony E; Ghanei M; Panahi Y
Exp Lung Res; 2016 May; 42(4):217-26. PubMed ID: 27266564
[TBL] [Abstract][Full Text] [Related]
40. Physiological and pathological views of peroxiredoxin 4.
Fujii J; Ikeda Y; Kurahashi T; Homma T
Free Radic Biol Med; 2015 Jun; 83():373-9. PubMed ID: 25656995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
